The results from an external quality control scheme for the assay of paracetarnol in serum are reported. A preferential methcd of assay has not become evident, but, as a result of the
scheme, some laboratories have changed or modified their techniques or have re-established the limits of detection.
The majority of laboratories were able to estimate paracetamol satisfactorily at those levels which are of clinical importance. The overall group performance has shown little change.
The programme has had considerable impact in so far as it has led to a mutually useful interchange of information and trouble shooting.
Self-poisoning with paracetamol has become a major problem in the last five or six years in the United Kingdom. It has increased to such an extent that in some areas the number of paracetamol overdoses is now greater than the number of salicylate overdoses (Proudfoot and Park, 1978) . This is mainly accounted for by the ease with which paracetamol can be purchased over the counter and also by the frequency with which it is now being prescribed in one form or another.
When taken in therapeutic doses paracetamol is a remarkably safe drug with few side effects. However, in the overdose case the development of hepatic necrosis can be a life-threatening complication (Davidson and Eastham, 1966; Maclean et aI., 1968; Toghill et al., 1969; Proudfoot and Wright, 1970) . Prescott et al. (1976) have shown that the urgent assay of plasma paracetamol concentration made on admission and related to the time after ingestion can be a guide to the severity of intoxication and used as a criterion for treatment. It is, therefore, important that an accurate measurement of the serum paracetamol level can be obtained quickly.
An increasing number of clinical biochemistry departments are now being requested to estimate paracetamol levels in the blood. There are several methods in general use and these fall mainly into two categories: ultraviolet (UV) spectrophotometry and colorimetry. Knepil (1974) and Chambers and Jones (1976) have reported on the accuracy that has been obtained in their own laboratories. However, whether this high level of accuracy can be maintained when studies embrace a group of laboratories is unknown.
Very few laboratories in the West Midlands Region appear to participate in any quality control scheme for drugs. Many use internal controls but this is no real substitute for an external scheme.
It was thought that a regional quality control scheme would be useful in assessing the performance of each individual laboratory. In March 1977, such a scheme was instituted in the West Midlands Region. Initially, 30 laboratories took part in the trial. Since then the number has increased to 36.
Methodology

SAMPLE PREPARATION
Plasma from the most recent out-of-date whole blood (from Dudley Road Hospital Blood Bank) was separated off under aseptic conditions. The plasma was screened for any interfering substance using the paracetamol method of Epton and Grove (1975) . Paracetamol, minimum guaranteed assay 98 % (BDH Chemicals, Ltd, Atherstone, Warwickshire), was weighed into the plasma and the solution was stored at 4°C for one week with periodic mixing.
Paracetarnol solutions are renowned for being unstable, and this is the main reason why commercially prepared quality control sera are not available at present. This has not been a problem illustrated in this programme because the majority of laboratories have analysed the specimens within a few days of receipt.
Three-millilitre aliquots were pipetted into 36 plain sample tubes. Tubes I, 19, and 36 were screened using the method of Epton and Grove (1975) to ensure a reasonable degree of homogeneity throughout the pipetting, These tubes were stored deep frozen so that if any problems relating to homogeneity arose after the results had been returned, a more precise method could be used as a check.
(E) Routh et al. (1968) : Saturate the serum with sodium chloride and extract with ether. Back extract into sodium hydroxide and aliquot the sodium hydroxide as follows: Test (alkali",) Blank ( Epton and Grove (1975) : Saturate the serum with ether-washed ammonium sulphate and extract with diethyl ether. Evaporate the ether to dryness and reconstitute the residue in absolute ethanol. Scan the solution in a spectrophotometer between 200 and 320 nm. Read peak optical density at 250 nm. (B) Dordoni et al. (1973) : Saturate the serum with sodium chloride and extract with diethyl ether. Scan the ether layer in a spectrophotometer between 200 and 320 nm. Read the optical density at 250 nm. (C) Modified Dordoni et al. (1973) : This method differs from (B) in that the pH of the serum is adjusted with phosphate buffer before extraction. Glynn and Kendal (1975) : Precipitate the protein from the serum by the addition of trichloroacetic acid. To an aliquot of the supernatant add hydrochloric acid and sodium nitrite followed by ammonium sulphamate or sulphamic acid. A yellow colour will develop on the addition of sodium hydroxide. Read in a colorimeter at 430 nm. (G) Love (1977) : Precipitate the protein from the serum with perchloric acid. Boil an aliquot of the supernatant for 10 minutes and then add a-cresol and ammonia. Boil for a further 2 minutes and read at 615 nm in a colorimeter.
Results and discussion
Specimens with paracetamol weighed-in, at concentrations ranging from 0 mg/l to 500 mg/l, have been distributed during the initial 12 months of the scheme. This has enabled each laboratory to evaluate their performance over the wide range of concentrations that they would normally encounter in paracetamol overdoses. Levels greater than 200 mg/I at 4 hours and greater than 75 mg/I at 10 hours may be considered 'action' levels for the treatment of patients.
It is generally considered that treatment to prevent liver damage is ineffective if initiated more than 10 hours after ingestion. It is nevertheless important that a serum paracetamol level is obtained as this will indicate the severity of the liver damage that is likely to occur and so alert the clinician to any problems that may develop.
The precision attained for samples with serum paracetamol concentrations of greater than 100 mg/I has been shown to be better than when serum levels of less than 100 mg/I have been assayed (Table I) . For levels greater than 100 mg/I the mean coefficient of variation (CV) is 11·2 (range 6·0-18'8), whereas for levels less than 100 mg/I the mean coefficient of variation is 38·2 (range 15'0-139'0). Since the calculation of CV is by ratio these results would be expected. In all cases colorimetric methods have given mean values greater than those obtained by the ultraviolet spectrophotometric methods. An example of this is displayed in Table 2 .
The possibility exists, therefore, that if a laboratory reports a falsely low result the patient may not be treated when he should have been. It also follows that a laboratory reporting a falsely high result may lead to a patient being treated when this is unnecessary. Variance indices were calculated for each sample for each laboratory as described by Whitehead (1977) . The mean used in these calculations was the value obtained when all results outside three standard deviations had been discarded and new standard deviations and coefficients of variation had been calculated using the remaining results. The chosen coefficient of variation was taken as 13'3, this being the mean coefficient of variation for the first 18 samples as calculated after all results outside three standard deviations had been omitted. The range of the coefficients of variation was 7·4-41·6.
The mean variance index score was calculated for each laboratory (Table 3) . Laboratory No. 16 returned two sets of results as each sample was analysed by two different methods.
The standard of performance attained by the majority of laboratories was of a reasonably high level, only seven of the 35 laboratories having It is felt, however, that for levels around 50 mg/I most laboratories are working at their limit of detection, and imprecision will be a contributing factor to a higher coefficient of variation. poor performance of method A seems to indicate that ammonium sulphate is not as efficient as sodium chloride in salting out the drug. The method of Glynn and Kendal (1975) , with or without modification, is the most widely used. Twenty-three laboratories in all use this method. Of these, nine have obtained scores of between 51 and 100, only five having a score greater than 100. This is a better-than-average performance compared with the results for other methods.
A mean variance index score of 33 was obtained by the laboratory using method G, this being the best score obtained for anyone method. This could, however, be misleading in view of the fact that only 32 results have been returned, only one laboratory having used this method. The main disadvantage with this method lies in the fact that the total paracetamol level (ie, free plus conjugated drug) is estimated and not, as in most other methods, the free paracetamol level. This leads to problems in interpretation of the results since treatrr.ent is based on the level of free drug in the plasma (Prescott et al., 1976) , hence if levels obtained by this methcd are used it may lead to the unnecessary treatment of a patient.
Unfortunately, the shortcomings of this method will not be illustrated in this scheme since the plasma distributed contains only the free drug. It would obviously be advantageous to have plasma containing both the free drug and its conjugates but the problems of obtaining large quantities of such plasma would be enormous.
The mean variance index scores have been calculated for each sample irrespective of method and are displayed in Figure I Generally speaking, colorimetric methods tended to give better overall statistical results than ultraviolet methods.
The main disadvantage with colorimetric techniques is their inability to detect the presence of interfering substances (Chafetz et al., 197 I; Mace and Walker, 1976) , leading to falsely elevated results. Ultraviolet methods differ in this respect in that any such compound is usually identified on the final ultraviolet scan.
In Table 4 the performance of each individual method is tabulated.
The mean variance index score for rr.ethods 8, D, and E is not strictly viable owing to the low number of results returned; however, it is felt that it may give a reasonable indication of the performance of each particular method. Methods D and E appear to be better ultraviolet methods, followed by methods Band C. In the latter two methods, the paracetamol is extracted from the biological sample using ether, and the ether layer is scanned in the spectrophotometer. The main disadvantage of this technique is that the ether may evaporate during transfer of solution and also during the time of scan. The main difference between methods Band C is that before salting out with sodium chloride the serum is buffered with a phosphate buffer in method C. This does not appear to make any significant difference. Method A uses ammonuim sulphate to salt out the paracetamol, whereas in all the other ultraviolet methods sodium chloride is used. The the mean variance index score (VIS) averages out at 69'7, which would be expected for a programme of this type. The notable feature in this Figure is that for specimens 9, 16,25, 35, and 36 a mean VIS of greater than 100 has been obtained. These specimens correspond to levels of 66, 22, 45, 15, and 30 mgjl respectively. This seems to indicate that at levels of approximately 75 or less the sensitivity of most methods is very poor. It follows, therefore, that the limit of detection of many of the methods must be around this level. I wish to thank Mr. W. B. Yeoman for valuable discussion and guidance, and the staff of all the laboratories who took part in the scheme. performance was achieved by eight other laboratories. The remaining laboratories have shown varying degrees of performance with no consistent trends.
In conclusion, it can be said that the general performance of all laboratories has been of a reasonably high standard. Most laboratories have been able to estimate paracetamol satisfactorily at levels that are of clinical importance. However, the inability of laboratories to estimate paracetamol concentrations of Jess than 50 mgjl has become evident.
No one preferential method of analysis has been forthcoming although the method of Glynn and Kendal (1975) , or slight modifications of it, have been extensively used. Several laboratories have, however, changed to this method.
The programme has had considerable impact in so far as it has led to a mutually useful interchange of information between participants.
Generally, drug monitoring is not widely quality controlled, especially in those areas for which all clinical chemistry laboratories are responsible, that is, assay of salicylate, barbiturates, etc. It is hoped that this report will generate more interest in these fields. The running overall mean variance index scores calculated as described by Whitehead (1977) have been used to assess the changes in performance of each individual laboratory. One slight difference from the United Kingdom National Quality Control Scheme (UK NQCS) is that instead of 40 results being used to calculate the ROMVIS only 10 results have been taken. The reason for this is that any change in performance will show up reasonably quickly, that is, within approximately three months, thus alerting any laboratory to any change so that laboratory action can be taken. A running plot of these results is shown in Figure  2 . The majority of the laboratories fall into three main categories. Six laboratories showed trends similar to that exhibited by laboratory A where performance was poor and no apparent attempt had been made to improve it. Five laboratories showed a general improvement in performance similar to that illustrated by laboratory B. Laboratory C attained a high performance which was maintained throughout the first year. A similar
